Via Surgical Ltd, a leading developer of surgical fixation solutions, today announced U.S. Food and Drug Administration 510(k) clearance of the FasTouch™ Absorbable Fixation System.
Via Surgical Ltd., a leading developer of novel surgical fixation technologies for mesh placement in hernia repair, announced today that it has appointed Morris E. Franklin Jr., M.D., F.A.C.S. as Medical Advisor.
Via Surgical Ltd., a leading developer of novel surgical fixation technologies for mesh placement in hernia repair, announced today the company has secured a $6M investment led by Benslie investment group.
Via Surgical Ltd., a leading developer of a deployable suture mesh fixation system for hernia repair, announced today it will introduce its lead product, FasTouch™, at the 1st World Conference on Abdominal Wall Hernia Surgery in Milan, Italy, from April 25 to 29, 2015.
Mr. Blumenreich, an investment banker at Raymond James, brings nearly 20 years of experience advising growth-oriented medical device companies and has completed numerous capital raising and M&A transactions in the aesthetics, cardiovascular, diabetes, diagnostics, general surgery, orthopedics, and spine subsectors.
AMIRIM, Israel, May 9, 2012 /PRNewswire/ —
Via Surgical Ltd., a leading developer of hernia mesh fixation technologies, announced today that it has appointed Karl A. LeBlanc, MD, MBA, FACS and David B. Earle MD, FACS as Medical Advisors.
Contact to learn more about Fastouch
If you are interested in FasTouch and would like to receive additional information, please complete the form below, and we will get back to you as soon as possible.